Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective oestrogen receptor modulators: a new paradigm for HRT

K C Baynes1, J E Compston

  • 1Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, UK.

Current Opinion in Obstetrics & Gynecology
|June 10, 1998
PubMed
Summary

Selective estrogen receptor modulators (SERMs) offer targeted estrogen benefits while minimizing side effects. Research explores their molecular mechanisms and clinical efficacy, particularly raloxifene, for future therapeutic advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

People living with HIV and fracture risk.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Self-perception of fracture risk: what can it tell us?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

Bone densitometry and clinical decision making.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2013
Same author

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.

Archives of osteoporosis·2012
Same author

Treatment failure in osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012

Area of Science:

  • Pharmacology and molecular biology of endocrine signaling pathways.

Background:

  • Selective estrogen receptor modulators (SERMs) are compounds designed to mimic or block estrogen's effects in specific tissues.
  • They aim to harness the therapeutic benefits of estrogen-like drugs while mitigating adverse effects.

Purpose of the Study:

  • To discuss the molecular biology of estrogen receptor signaling in relation to SERM pharmacology.
  • To review clinical trial data for raloxifene, a prominent SERM.
  • To outline future developments in SERM research.

Main Methods:

  • Review of molecular biology principles governing estrogen receptor signaling.
  • Analysis of pharmacological effects of SERMs.
  • Documentation of clinical trial outcomes for raloxifene.

Related Experiment Videos

Main Results:

  • SERMs exhibit tissue-specific agonist or antagonist activity.
  • Raloxifene demonstrates a specific clinical profile, with its trial data presented.
  • Understanding of estrogen receptor signaling is crucial for SERM action.

Conclusions:

  • SERMs represent a targeted approach to hormone-related therapies.
  • Raloxifene serves as a key example of SERM application and research.
  • Further research into SERMs holds promise for improved treatment strategies.